Project Details
Projekt Print View

Functional characterization of neurotransmitter-mediated signaling in human neocortical development

Subject Area Developmental Neurobiology
Term from 2016 to 2018
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 324874657
 
Final Report Year 2020

Final Report Abstract

The human neocortex is the brain area responsible for many different functions including, processing of sensory information, language, and cognition. The neocortex of humans is composed of many more cells than that for example of the mouse, a model organism used frequently in biomedical research. It is therefore a great evolutionary and medical interest to understand the cellular and molecular mechanisms that drive the development of our enlarged neocortex and thus give rise to our complex cognitive traits. Previous work on rodents has demonstrated that neurotransmitter signaling occurs already at earliest stages of brain development - even before synapses are formed - when stem and progenitor cells divide to generate neurons. In our study, we have for the first time to our knowledge performed calcium imaging in primary human neocortical tissue during the second trimester of gestation. We found responses to diverse neurotransmitters starting at the end of the first trimester of gestation. We developed a new approach that allowed us to link the recorded calcium responses to the molecular cell identity through a technique called “single-cell RNA-sequencing”. This method allowed us to identify that responses to neurotransmitter stimulation were already specific to cell types and even cell states at these early developmental stages. These findings have several implications. The high specificity of early neurotransmitter signaling implies a functional importance for brain development and possibly also brain evolution. Moreover, any dysregulation might lead to disease. For example, mutations in neurotransmitter receptors have been reported in brain malformations and many drugs, such as anti-epileptics and anti-depressants target neurotransmitter systems thus potentially interfering with fetal brain development if administered during pregnancy.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung